Tyson Ruetz

About

Tyson Ruetz, PhD is a scientist and biotech founder working at the intersection of brain aging, regeneration, and drug discovery. ReneuBio lists him as Co-founder & Advisor, and Stanford/Nature sources show him as a Stanford-affiliated researcher who led a 2024 Nature study on CRISPR screens for regulators of ageing in neural stem cells. Earlier in his career, the University of Edinburgh’s Centre for Regenerative Medicine reported that he won the 2014 Wilmut Prize for his PhD work on cellular reprogramming.

Areas of interest